MedTrace Logo

Control of Hyperglycemia After Cardiac Surgery: CHyCS Trial

NCT02574156 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2022-11-04

No results posted yet for this study

Summary

The investigators aim to study the impact of a strategy of a intensive glycemic control in patients undergoing cardiac surgery.

Conditions

Interventions

DRUG

Insulin

All patients will receive insulin. However, the infusion flow will be different according to the group.

Sponsors & Collaborators

  • InCor Heart Institute

    collaborator OTHER

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Eduesley Santana Santos, Ph.D · University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-08-01
Completion
2019-04-01

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02574156 on ClinicalTrials.gov